Aaron joined Mendel in July 2007 with twenty years of experience in both the biotechnology and energy industries. Prior to Mendel, Aaron structured and negotiated many collaborations and alliances at Amgen, Inc where he was responsible for global outlicensing activities. Prior to Amgen, he held various positions in operations, finance, and business development at Atlantic Richfield Company. Aaron holds a BBA from Texas Tech University and an MBA from UCLA. |